18
Views
18
CrossRef citations to date
0
Altmetric
Original Article

The role of heme oxygenase-1 in systemic-onset juvenile idiopathic arthritis

, , , , , & show all
Pages 302-308 | Received 04 Nov 2008, Accepted 09 Jan 2009, Published online: 02 Jan 2014

References

  • Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol. 1997;37:517–54.
  • Tsuchihashi S, Fondevia C, Kupiec-Weglinski JW. Heme oxy-genase system in ischemia and reperfusion injury. Ann Transplant. 2004;9:84–7.
  • Otterbein LE, Soares MP, Yamashita K, Bach FH. Heme Oxy-genase-1: unleashing the protective properties of heme. Trends Immunol. 2003;24:449–55.
  • Katori M, Busuttil RW, Kupiec-Weglinski JW. Heme oxygenase-1 system in organ transplantation. Transplantation. 2002;74: 905–12.
  • Otterbein LE, Choi AM. Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol. 2000;279:1029–37.
  • Morse D, Pischke SE, Thou Z, Davis RJ, Flavell RA, Loop T, et al. Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem. 2003;278:36993–8.
  • Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med. 2000;6:422–8.
  • Brouard S, Berberat PO, Tobiasch E, Seldon MP, Bach FH, So-ares MP. Heme oxygenase- 1-derived carbon monoxide requires the activation of transcription factor NF-KB to protect endothelial cells from tumor necrosis factor-a-mediated apoptosis. J Biol Chem. 2002;277: 17950–61.
  • Inoue S, Suzuki M, Nagashima Y, Suzuki S, Hashiba T, Tsuburai T, et al. Transfer of heme oxygenase-1 cDNA by a replication-deficient adenovirus enhances interleukin-10 production from alveolar macrophages that attenuates lipopolysaccharide-induced acute lung injury in mice. Hum Gene Ther. 2001;12:967–79.
  • Hashiba T, Suzuki M, Nagashima Y, Suzuki S, Inoue S, Tsuburai T, et al. Adenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in mice. Gene Ther. 2001;8:1499–507.
  • Yet SF, Tian R, Layne MD, Wang ZY, Maemura K, Solovyeva M, et al. Cardiac-specific expression of heme oxygenase-1 pro-tects against ischemia and reperfusion injury in transgenic mice. Circ Res. 2001;89:168–73.
  • Tsuchihashi S, Livhits M, Zhai Y, Busuttil RW, Araujo JA, Kupiec-Weglinski JW. Basal Rather Than Induced Heme Oxy-genase-1 Levels Are Crucial in the Antioxidant Cytoprotection. J Immunol. 2006;177: 4749–57.
  • Tsui TY, Wu X, Lau CK, Ho DW, Xu T, Siu YT, et al. Pre-vention of chronic deterioration of heart allograft by recombinant adeno- associated virus-mediated heme oxygenase-1 gene trans-fer. Circulation. 2003;107:2623–9.
  • Kawahito Y, Kondo M, Tsubouchi Y, Hashiramoto A, Bishop-Bailey D, Inoue K, et al. 15-deoxy-412,14-PGJ2 induces syno-viocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J Clin Invest. 2000;106: 189–97.
  • Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-inflam-matory effect of interleukin-10 in mice. Nat Med. 2002;8:240–6.
  • Cssidy JT, Petty RE. Textbook of pediatric rheumatology, 5th edn. Philadelphia: W. B. Saunders; 2005.
  • Hadchouel M, Prieur AM, Griscelli C. Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. J Pediatr. 1985;106:561–6.
  • Sawhney S, Woo P, Murray KJ. Macrophage activation syn-drome: a potentially fatal complication of rheumatic disorders. Arch Dis Child. 2001;85:421–6.
  • Imagawa T, Katakura S, Mori M, Aihara Y, Mitsuda T, Yokota S. A case of macrophage activation syndrome developed with sys-temic juvenile rheumatoid arthritis. Ryumachi. 1997;37:487–92.
  • Billiau AD, Roskams T, Van Damme-Lombaerts R, Matthys P, Wouters C. Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-y-producing lymphocytes and IL-6 and TNF-a-producing mac-rophages. Blood. 2005;105: 1648–51.
  • Kirino Y, Takeno M, Iwasaki M, Ueda A, Ohno S, Shirai A, et al. Increased serum HO-1 in hemophagocytic syndrome and adult-onset Still's disease: use in the differential diagnosis of hyped-erritinemia. Arthritis Res Ther. 2005;7:616–24.
  • Ravelli A, Silvia MM, Angela P, Cristina B, Tiziana F, Nicolino R, et al. Preliminary diagnostic guidelines for macrophage acti-vation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr. 2005;146:598–604.
  • Filipovich AH. Hemophagocytic lymphohistiocytosis and related disorders. Curr Opin Allergy Clin Immunol. 2006;6:410–5.
  • Yokota S. Interleukin 6 as a therapeutic target in systemic-onset juvenile idiopathic arthritis. Curr Opin Rheumatol. 2003;15:581–6.
  • Deshane J, Wright M, Agarwal A. Heme oxygenase-1 expression in desease states. Acta Biochim Pol. 2005;52: 273–84.
  • Takahashi T, Morita K, Akagi R, Sassa S. Heme-Oxygenase-1 : a novel therapeutic target in oxidative tissue injuries. Curr Med Chem. 2004;11:1545–61.
  • Kirino Y, Takeno M, Murakami S, Kobayashi M, Kobayashi H, Miura K, et al. Tumor necrosis factor alpha acceleration of inflammatory responses by down-regulating heme oxygenase 1 in human peripheral monocytes. Arthritis Rheum. 2007;2:464–75.
  • Okada Y, Shinohara M, Kobayashi T, Inoue Y, Tomomasa T, Kobayashi T, et al. Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children. J Pediatr. 2003;3:363–7.
  • Morimoto K, Ohta K, Yachie A, Yang Y, Shimizu M, Goto C, et al. Cytoprotective role of heme oxygenase-1 in human kidney with various renal disease. Kidney Int. 2001;60:1858–66.
  • Yang Y, Ohta K, Shimizu M, Morimoto K, Goto C, Nakai A, et al. Selective protection of renal tubular epithelial cells by heme oxygenase-1 during stress-induced injury. Kidney Int. 2003;64:1302–9.
  • Ohta K, Yachie A, Fujimoto K, Kaneda H, Wada T, Toma T, et al. Tubular injury as a cardinal pathologic feature in human heme oxygenase-1 deficiency. Am J kidney Dis. 2000;35:868–70.
  • Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest. 1999; 103:129–35.
  • Alam J, Camhi S, Choi AM. Identification of a second region upstream of the mouse heme oxygenase-1 gene that functions as a basal level and inducer-dependent transcription enhancer. J Biol Chem. 1995;270: 11977–84.
  • Wasserman WW, Fahl WE. Functional antioxidant responsive elements. Proc Natl Acad Sci USA. 1997;94:5361–6.
  • Kashiwagi Y, Kawashima H, Nishimata S, Nagao R, Watanabe K, Takekuma K, et al. Extreme efficiency of anti-interleukin 1 agent (anakinra) in a Japanese case of CINCA syndrome. Clin Rheumatol. 2008;27:277–9.
  • Janssen R, Verhard E, Lankester A, Ten Cate R, van Dissel JT. Enhanced interleukin-lbeta and interleukin-18 release in a patient with chronic infantile neurologic, cutaneous, articular syndrome. Arthritis Rheum. 2004;50: 3329–33.
  • Mizuno K, Toma T, Tsukiji H, Okamoto H, Yamazaki H, Ohta K, et al. Selective expansion of CD161'ghCCR2- subpopulation of circulating monocytes with preferential production of haem oxygenase-1 in response to acute inflammation. Clin Exp Immunol. 2005;142:461–70.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.